We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+8.7%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$9.99B
AUM Growth
+$475M
Cap. Flow
-$113M
Cap. Flow %
-1.13%
Top 10 Hldgs %
8.79%
Holding
968
New
62
Increased
353
Reduced
363
Closed
57

Top Buys

Rank Stock Value
1
RBA icon
RB Global
RBA
+$25M
2
FCNCA icon
First Citizens BancShares
FCNCA
+$23.1M
3
NEWT icon
NewtekOne
NEWT
+$21.4M
4
AGO icon
Assured Guaranty
AGO
+$18.9M
5
TECH icon
Bio-Techne
TECH
+$18.7M

Sector Composition

Rank Sector Weight
1 Industrials 27.54%
2 Technology 18.26%
3 Consumer Discretionary 12.96%
4 Financials 12.6%
5 Materials 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMRK icon
901
Newmark Group
NMRK
$2.68B
$81.1K ﹤0.01%
11,452
-817
-7% -$6.55K
CRBU icon
902
Caribou Biosciences
CRBU
$150M
$78.1K ﹤0.01%
14,700
+4,100
+39% +$25.5K
GPRO icon
903
GoPro
GPRO
$124M
$77.9K ﹤0.01%
15,496
-1,106
-7% -$5.97K
TEAD
904
Teads Holding Co
TEAD
$70.3M
$73.4K ﹤0.01%
17,779
-1,269
-7% -$5.76K
MYPS icon
905
PLAYSTUDIOS Inc
MYPS
$76.3M
$64K ﹤0.01%
17,332
-1,238
-7% -$5.01K
BVS icon
906
Bioventus
BVS
$893M
$53.5K ﹤0.01%
50,000
-191,306
-79% -$366K
RMNI icon
907
Rimini Street
RMNI
$454M
$49.8K ﹤0.01%
12,097
-864
-7% -$3.89K
CURV icon
908
Torrid Holdings
CURV
$260M
$48.9K ﹤0.01%
11,210
-800
-7% -$2.53K
ORGO icon
909
Organogenesis Holdings
ORGO
$315M
$38.3K ﹤0.01%
17,968
-1,283
-7% -$3.17K
SPIR icon
910
Spire Global
SPIR
$440M
$33.4K ﹤0.01%
6,250
CANO.WS
911
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$8K ﹤0.01%
49,999
ACCO icon
912
Acco Brands
ACCO
$390M
-21,794
Closed -$122K
AGEN
913
Agenus
AGEN
$329M
-860
Closed -$40.5K
ALEX
914
DELISTED
Alexander & Baldwin
ALEX
-106,742
Closed -$2M
BDC icon
915
Belden
BDC
$4.56B
-2,862
Closed -$206K
BHR
916
Braemar Hotels & Resorts
BHR
$160M
-417,566
Closed -$1.72M
CLDT
917
Chatham Lodging
CLDT
$622M
-276,816
Closed -$3.4M
COLL icon
918
Collegium Pharmaceutical
COLL
$1.17B
-14,477
Closed -$336K
CVGW
919
DELISTED
Calavo Growers
CVGW
-44,841
Closed -$1.32M
EGBN icon
920
Eagle Bancorp
EGBN
$838M
-5,006
Closed -$221K
EIG icon
921
Employers Holdings
EIG
$941M
-90,166
Closed -$3.89M
ELF icon
922
e.l.f. Beauty
ELF
$4.85B
-13,900
Closed -$769K
ENS icon
923
EnerSys
ENS
$6.74B
-15,000
Closed -$1.11M
EQH icon
924
Equitable Holdings
EQH
$13.3B
-30,000
Closed -$861K
FBIN icon
925
Fortune Brands Innovations
FBIN
$5.88B
-106,762
Closed -$6.1M

Similar funds

Royce & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Royce & Associates held 968 positions worth $9.99B, up 5% from $9.52B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.

Royce & Associates's Q1 2023 filing shows 62 new, 353 increased, 363 reduced and 57 closed positions. Its largest new stake was Innovex International: 284,752 shares worth $8.17M. The largest sale was Interparfums, an estimated $35.1M.

By sector, the portfolio is most concentrated in Industrials at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Royce & Associates's largest Q1 2023 buy was Innovex International: 284,752 shares worth $8.17M.
  • Royce & Associates added most to RB Global in Q1 2023, an estimated $25M increase.
  • Royce & Associates's biggest Q1 2023 reduction was Interparfums, cutting an estimated $35.1M.
  • Royce & Associates fully exited nVent Electric in Q1 2023, selling an estimated $7.89M.
  • Royce & Associates's ten largest holdings make up 8.8% of its $9.99B portfolio in Q1 2023.
  • Royce & Associates opened 62 new positions and closed 57 in Q1 2023.
  • Royce & Associates's portfolio value rose 5% quarter-over-quarter to $9.99B.

Based on Royce & Associates's 13F filing for Q1 2023, filed 4 May 2023.